Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives
Genes · 2023
DOI: 10.3390/genes14061252 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Gerardo Cazzato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari, 70124 Bari, Italy. Hauptthemen laut MEDLINE: B7-H1 Antigen, Melanoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Programmed death-ligand 1 (PD-L1) is the primary ligand of the receptor programmed death-1 (PD-1) which is constitutively expressed or activated in myeloid, lymphoid (T, B and NK), normal epithelial cells, and cancer. The PD-1/PD-L1 interaction is crucial for the physiological development of immunological tolerance but also in the development of the cancer. Among these, malignant melanoma represents a tumour in which the immunohistochemical expression of PD-L1 is important to guide future therapeutic choices based on the presence/absence of expression. Various clones have been used over time for immunohistochemical determination, and different results and heterogeneity remain among the various studies in the literature. We perform a narrative review of the present studies in order to discuss and take stock of what certain achievements have been made in this field, what challenges remain, and what possible solutions can be found.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari, 70124 Bari, Italy.
- Odontomatostologic Clinic, Department of Innovative Technologies in Medicine and Dentistry, University of Chieti, 66100 Chieti, Italy.
- Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari, 70124 Bari, Italy.
- Medical Oncology, Dario Camberlingo Hospital, 72021 Francavilla Fontana, BR, Italy.
- Pathology Unit, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, FG, Italy.
ORCID-Profile: Gerardo Cazzato, Teresa Lettini, Anna Colagrande, Irma Trilli, Francesca Ambrogio, Carmelo Laface, Paola Parente, Eugenio Maiorano, Giuseppe Ingravallo
Zitieren
APA
Cazzato, G., Lettini, T., Colagrande, A., Trilli, I., Ambrogio, F., Laface, C., Parente, P., Maiorano, E., & Ingravallo, G. (2023). Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives. Genes. https://doi.org/10.3390/genes14061252
Vancouver
Cazzato G, Lettini T, Colagrande A, Trilli I, Ambrogio F, Laface C, et al. Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives. Genes. 2023. doi:10.3390/genes14061252
BibTeX
@article{Cazzato2023,
author = {Cazzato, Gerardo and Lettini, Teresa and Colagrande, Anna and Trilli, Irma and Ambrogio, Francesca and Laface, Carmelo and Parente, Paola and Maiorano, Eugenio and Ingravallo, Giuseppe},
title = {Immunohistochemical Expression of Programmed Cell Death Ligand 1 (PD-L1) in Human Cutaneous Malignant Melanoma: A Narrative Review with Historical Perspectives},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14061252}
}
EUVIMED